Figures
Abstract
Streptococcus suis is an emerging zoonotic agent causing meningitis and septicemia. Outbreaks in humans in China with atypical cases of streptococcal toxic shock-like syndrome have been described to be caused by a clonal epidemic S. suis strain characterized as sequence type (ST) 7 by multilocus sequence typing, different from the classical ST1 usually isolated in Europe. Previous in vitro studies showed that Toll-like receptor (TLR) 2 plays a major role in S. suis ST1 interactions with host cells. In the present study, the in vivo role of TLR2 in systemic infections caused by S. suis ST1 or ST7 strains using TLR2 deficient (TLR2−/−) mice was evaluated. TLR2-mediated recognition significantly contributes to the acute disease caused by the highly virulent S. suis ST1 strain, since the TLR2−/− mice remained unaffected when compared to wild type (WT) mice. The lack of mortality could not be associated with a lower bacterial burden; however, a significant decrease in the induction of pro-inflammatory mediators, as evaluated by microarray, real-time PCR and protein assays, was observed. On the other hand, TLR2−/− mice infected with the epidemic ST7 strain presented no significant differences regarding survival and expression of pro-inflammatory mediators when compared to the WT mice. Together, these results show a TLR2-independent host innate immune response to S. suis that depends on the strain.
Citation: Lachance C, Segura M, Gerber PP, Xu J, Gottschalk M (2013) Toll-Like Receptor 2-Independent Host Innate Immune Response against an Epidemic Strain of Streptococcus suis That Causes a Toxic Shock-Like Syndrome in Humans. PLoS ONE 8(5): e65031. https://doi.org/10.1371/journal.pone.0065031
Editor: Dario S. Zamboni, University of São Paulo, Brazil
Received: February 19, 2013; Accepted: April 20, 2013; Published: May 28, 2013
Copyright: © 2013 Lachance et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by Natural Sciences and Engineering Research Council of Canada (grant #154280 and DAS #380299) and Canadian Institutes of Health Research (to MG). CL is the recipient of a Fonds Québécois de la Recherche sur la Nature et les Technologies (FQRNT) postdoctoral fellowship award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Introduction
Streptococcus suis serotype 2 is a major swine pathogen and an important emerging zoonotic agent [1], [2]. In western countries, S. suis infections in humans have been usually restricted to workers in close contact with pigs or pork by-products. However, in South East and East Asia, this pathogen affects not only the population at risk, but also the general population, presenting a significant public health concern [3]. In fact, it has been shown that S. suis is the primary cause of adult meningitis in Vietnam, the secondary cause in Thailand and the tertiary cause in Hong Kong [4]–[6]. Two deadly human outbreaks of S. suis occurred in China within the last years, with the atypical characteristic of most patients presenting a streptococcal toxic shock-like syndrome (STSLS) that had rarely been reported beforehand [7]. Both outbreaks were caused by the same clonal epidemic S. suis strain, characterized as sequence type (ST) 7 by multilocus sequence typing (MLST), which is different from the classical highly virulent ST1 usually isolated in Europe [7].
Virulence factors as well as the pathogenesis of S. suis infection have partially been elucidated [8]. It is unknown how S. suis, despite its low quantities on mucosal surfaces, is able to traverse this first line of host defence to disseminate in the host and initiate disease. Survival of the organism once in the bloodstream is facilitated by the capsular polysaccharide, which efficiently hampers phagocytosis [8]. Furthermore, the hemolysin (suilysin) seems to protect bacteria against complement-mediated uptake and killing by neutrophils, macrophages and dendritic cells [9]. S. suis can thus be considered a truly extracellular systemic pathogen. In the event that S. suis fails to cause acute fatal septicemia, bacteria are able to reach the central nervous system via mechanisms that are only partially elucidated. It has been reported that S. suis interacts with brain microvascular endothelial cells and the choroid plexus epithelial cells to breach the blood-brain barrier [10], [11]. Either in the bloodstream or at the central nervous system, S. suis will elicit a rapid and exaggerated inflammatory immune response that has been associated with mortality and clinical signs of the disease [12]. Interestingly, differences in virulence exist between S. suis serotype 2 strains isolated in North America (different STs, intermediate virulence), Europe (ST1, highly virulent) and the ST7 strain responsible for the STSLS outbreak in China (epidemic strain) [13]. Although the exact virulence factors involved in such differences are still poorly understood, their virulence degree has been suggested to correlate with their respective capacity to induce exaggerated inflammation [14].
Toll-like receptors (TLRs) are critical sensors that activate the innate immune response [15], [16]. Once microbial ligands bind to these receptors, downstream signal transduction pathways are activated resulting in the upregulation and suppression of many genes, leading to the release of many cytokines and chemokines responsible for inflammation and sometimes damage to the host. On the other hand, pathogen recognition by these receptors may be essential to prevent failure of the innate immune system to detect traces of microorganisms before systemic invasion [17]. In the case of S. suis, in vitro studies performed with heat-killed whole cells or live bacteria of classical ST1 European strains showed that TLR2 is mainly implicated in cell activation after stimulation of different murine and human cells [18], [19]. More recently, in vitro studies carried out with the whole cells of the epidemic ST7 strain and human peripheral blood cells showed that not only TLR2 but also TLR6 and TLR9 play an important role on cell activation [20]. Since inflammation has been described as playing a fundamental role in the pathogenesis of the toxic shock-like syndrome caused by S. suis infection [3], it is then hypothesized that there are differences on the TLR2 in vivo activation pattern between strains of S. suis with different virulent potential. To investigate such hypothesis, mortality, bacterial load, and genes regulated in mice following experimental infections with either a highly virulent ST1 European strain or the Chinese epidemic ST7 strain were performed. Expression of important inflammatory mediators (proteins) was also measured. Results clearly showed a TLR2-dependent or -independent innate immune response depending on the strain responsible for the infection, suggesting different mechanisms of cell activation.
Materials and Methods
S. suis strains and growth conditions
S. suis serotype 2 strain P1/7 (highly virulent ST1), isolated from a case of meningitis in Europe [21] and SC84 (epidemic ST7), isolated from a case of STSLS in China [21] were used for experimental infections [22]. Both strains have already been sequenced [21]. Bacteria were grown as previously described in Todd-Hewitt broth (THB) [12]. Aliquots of bacterial suspension were plated using an Autoplate® 4000 (Spiral Biotech) onto sheep blood agar plates to accurately determine bacterial concentrations.
Mice and experimental infections
Wild type (WT) 7-week-old female C57BL/6 mice or TLR2−/− (B6.129-Tlr2tmlKir/J) mice (Jackson Laboratory) were acclimatized to standard laboratory conditions with unlimited access to water and rodent chow. This study was carried out in strict accordance with the recommendations and approved by University of Montreal Animal Welfare Committee guidelines and policies (Permit Number: RECH-1570) in order to minimize suffering. On the day of the experiment, one ml of a bacterial suspension of 1×107 CFU or the bacteria vehicle solution (sterile THB) was administrated by intraperitoneal injection. Optimal bacterial concentration was chosen based on previous studies with WT mice [23] and on preliminary experiments with TLR2−/− mice (data not shown). Mice were euthanized at 6 h post-infection (p.i.) for the microarray, real-time RT-qPCR, and cytokines analysis. This time-point was chosen based on previous microarray studies of WT mice infected with the same strains [24]. For survival studies, clinical signs and mortality were monitored during 72 h. Dose of infection and p.i. times were selected based on preliminary results and previous work [23].
Measurement of blood bacterial loads
Following infection, blood bacteremia was assessed in surviving mice by collecting a 5 μl blood sample from the tail up to day 6 p.i. Proper dilutions were plated and counted as described above.
Collection, homogenization and extraction of spleen total RNA
At 6 h p.i., spleens were removed, cut in pieces and put in 1.5 mL of RNAlater solution (Qiagen) for stabilization of total RNA. Approximately 25 mg of spleen was then disrupted and homogenized in 600 μl of lysis buffer (Qiagen) using a rotor stator homogenizer (Tissue-tearor model 398, Biospec products). Total RNA from homogenized tissue was isolated and purified using an RNeasy mini kit with on-column DNase digestion (Qiagen) and kept at -80°C.
Illumina microarray analysis
Microarray experiments were performed using the Illumina whole-genome expression beadchips technology platform (Illumina). Prior to the microarray experiment, the total RNA quality was assessed using the Agilent 2100 Bioanalyzer (Agilent Technologies). Microarray tests were performed according to manufacturer’s instructions. Total RNA was hybridized to the MouseRef-8 v.2 Illumina BeadChip. This BeadChip targets 25,697 RefSeq transcripts and covers over 19,100 unique genes. Sample positions on chips were randomly distributed.
Text files containing the signal and detection P-values per probe for each sample were imported into FlexArray software v.1.61 (McGill University and Genome Quebec Innovation Centre). Data were first raw-filtered and then further pre-processed by applying a lumi filter for normalizing data. An analysis of variance (ANOVA) was used to look for differentially expressed genes between infected and mock-infected groups, for TLR2−/− and WT mice infected with either the ST1 or ST7 strain. In order to maintain manageable datasets, differentially expressed genes were defined by fold changes smaller or greater than 3-folds with an accompanying P-value ≤0.05.
Validation of microarray data by qPCR
Eight genes were selected to validate microarray results by quantitative real-time RT-PCR (qPCR), which was executed to conform to the qPCR MIQE guidelines [25], [26]. Primers (Integrated DNA technologies) used for detection of genes were all verified to have reaction efficiencies between 90–110% (Table 1). Normalization of the data was done using the two most experimentally determined stable reference genes, Actin-β and β-2 microglobulin (β2m). Fold-change of gene expression was calculated using the normalized gene expression (ΔΔCq) calculation method of the CFX software manager v.2.1 (Bio-Rad). Samples from mock-infected WT mice were used as calibrator.
Plasma cytokine and chemokine levels
Blood was collected from 6 h-euthanized mice and stabilized with EDTA. Time p.i. was chosen based on previous studies [12], [24]. Plasma supernatants were collected and kept at –80°C. Plasmatic concentrations of TNF, IL-6, IFN-γ, CCL2, CCL3, CCL4, CXCL1, and CXCL2 were determined using a custom-made 8-plex cytokine Milliplex panel (Millipore) according to manufacturer’s instructions. Acquisition was performed on a Luminex 100 platform (Luminex) and analysis performed using Beadview Multiplex Data Analysis Software v.1.0 (Upstate/Millipore).
Statistical analysis
Data are presented as the mean ± standard error of the mean or geometric mean with 95% confidence interval where appropriate. Unpaired t-tests where appropriate were performed to find statistical differences between groups. The Kaplan–Meier method and log-rank Mantel-Cox tests were used to compare the survival rates of the studied groups. P<0.05 was considered statistically significant.
Results
TLR2-dependent or –independent survival during S. suis infection
As shown in Figure 1A, WT mice infected with the S. suis ST1 strain started dying at 20 h p.i. and 45% had succumbed by 72 h. On the other hand, TLR2−/− mice infected with the same strain showed no mortality at the same time point (P = 0.004), even up to 96 h p.i. (data not shown). Survival of WT and TLR2−/− mice after infection with the ST7 strain showed no significant differences (Fig. 1B). Indeed, WT and TLR2−/− mice started dying at 16 h p.i. and 60% of mice had succumbed by 72 h (P = 0.745). These data confirmed the higher virulence of the ST7 strain compared to the ST1 strain, especially during the first hours of infection, as previously observed in C57BL/6 mice [24]. Results obtained suggest that mouse mortality after infection with the ST1 strain is, at least partially, related to the presence of TLR2. On the other hand, high mortality generated by the ST7 strain was shown to be independent of this receptor. Similar results were obtained when experiments were repeated (data not shown). WT and TLR2−/− mice infected with either strain had similar levels of bacteremia (Fig. 2). Interestingly, mean levels of 104 CFU/mL were uniformly observed 6 days p.i. for both strains in WT and TLR2−/− mice, without the presence of clinical signs.
Survival of 7-week-old C57BL/6 mice (n = 13 mice per infection group) or TLR2−/− mice (n = 14 mice per infection group) inoculated by intraperitoneal injection with 1×107 CFU of either P1/7 strain (ST1; panel A) or SC84 strain (ST7; panel B) was monitored for 72 h. * P<0.01, indicates statistically significant differences between infected WT and TLR2−/− mouse groups, as determined by Log-rank (Mantel-Cox) test.
C57BL/6 mice (n = 13 mice per group) or TLR2−/− mice (n = 14 mice per group) were inoculated by intraperitoneal injection with 1×107 CFU of either S. suis strain P1/7 (ST1) or SC84 (ST7). At 6 h (panel A), day 1 (panel B), day 3 (panel C), and day 6 (panel D) post-infection, 5 μl of blood was harvested from the tail of infected mice and proper dilutions were plated on blood agar plate to assess blood bacteremia. Data of individuals are presented including geometric mean with 95% confidence interval. No significant differences (P>0.05) between infected TLR2−/− mice and their WT counterpart were observed as determined by ANOVA.
Expression of several mouse genes after S. suis infection by the ST1 strain, but not by the ST7 strain, partially depends on TLR2
To investigate survival differences observed between WT and TLR2−/− mice infected with the ST1 strain but not between mouse counterparts infected with the ST7 strain, a whole genome microarray study was undertaken. As shown in Table S1, several genes were upregulated in WT and TLR2−/− mice at 6 h p.i. by both strains when compared to mock-infected mice. Several of these genes were related to proinflammatory cytokines, chemokines, and signaling pathways. Interestingly, this induction was generally lower in TLR2−/− infected mice, particularly in mice infected with the ST1 strain. Many proinflammatory chemokines (such as CCL2, CCL3, CCL4, CCL7, CCL11, CXCL1, and CXCL2) were up-regulated to a lower level in TLR2−/− mice infected with the ST1 strain than in WT counterparts. In contrast, no significant differences in the level of CCL2, CCL3, CCL4, CCL7, CCL11, CXCL1, and CXCL2 were observed between TLR2−/− and WT mice infected with ST7 strain. Surprisingly, no significant differences in the up-regulation levels of IL-6 and TNF, two important cytokines involved in sepsis, were observed by microarray between TLR2−/− and WT mice infected with either of the strains (Table S1).
Reduction in the expression levels of several proinflammatory genes in ST1-infected TLR2−/− mice compared to WT counterparts, but not in those infected with the ST7 strain, was confirmed by qRT-PCR. A significant reduction in the levels of CCL3, CCL4, CXCL1, CXCL2, and CCL2 gene expression in TLR2−/− mice infected with the highly virulent ST1 strain compared to WT infected mice was observed (Fig. 3A–E). Different from the results obtained by microarray, expression of IL-6 was also significantly reduced in ST1-infected TLR2−/− mice compared to WT mice (Fig. 3F). In contrast, no significant differences were observed between ST7-infected groups of mice for these chemokines/cytokines (Fig. 3A–F). TNF gene up-regulation was not significantly different between groups of mice infected with either of the strains, confirming microarray results (Fig. 3G).
Proinflammatory cytokine and chemokine gene expression in TLR2−/− mice infected with S. suis highly virulent strain ST1 is lower than wild-type counterparts, whereas no major differences are observed between epidemic strain ST7-infected groups. Quantitative PCR analysis of cytokine and chemokine gene expression in C57BL/6 and TLR2−/− mice infected with 1×107 CFU of either S. suis strain P1/7 (ST1) or SC84 (ST7). Total RNA was isolated from spleen samples at 6 h post-infection. Tested cytokines and chemokines are indicated at the top of each panel. Data represent mean mRNA relative fold induction values ± SEM. * P<0.05, indicates TLR2−/− group significantly different from corresponding C57BL/6 mice as determined by t-test.
Production of high levels of IFN-γ has been associated to the STSLS induced by the ST7 strain [13], [24]. Expression of this cytokine was not significantly dependent on the presence of TLR2 for either strain of S. suis (Fig. 3H).
ST1 and ST7 differences in TLR2 dependency are also observed at chemokine and cytokine protein levels
Protein expression of proinflammatory chemokines and cytokines is tightly regulated at transcriptional and post-transcriptional levels. A Luminex assay was thus performed to confirm qPCR results. Similarly to qPCR and/or microarray results, protein levels of CCL2, CCL3, CCL4, CXCL1 and IL-6 were significantly lower only in TLR2−/− mice infected with the ST1 strain than in WT counterparts (Fig. 4A–C, E, F). CXCL2 expression was also significantly different between these two groups of mice. However, a slight reduction of this chemokine expression was also noticeable in ST7-infected TLR2−/− mice when compared to WT mice (Fig. 4D). Although not detected either by microarray or qPCR, TNF protein expression was clearly and significantly reduced in ST1-infected TLR2−/− mice, whereas no significant changes were observed in mice infected with the ST7 strain (Fig. 4G). Protein expression of IFN-γ was also monitored and no significant differences were observed in infected TLR2−/− mice when compared to WT mice, confirming gene expression results (Fig. 4H).
Production of proinflammatory cytokines and chemokines in TLR2−/− mice infected with S. suis highly virulent strain ST1 is lower than in wild type counterparts, whereas no differences are observed when animals are infected with epidemic strain ST7. Plasma levels of cytokines and chemokines in C57BL/6 and TLR2−/− mice infected with 1×107 CFU of S. suis strain P1/7 (ST1) or SC84 (ST7) for 6 h, as quantified by Luminex. Plasma samples were tested for the cytokines and chemokines indicated at the top of each panel. Data represent mean values ± SEM in pg/ml. * P<0.05 indicates statistically significant differences between infected TLR2−/− group and its wild-type infected counterpart as determined by t-test.
Discussion
Inflammation plays an important role in the pathogenesis of S. suis-induced septicemia and meningitis [3]. Cases in humans and pigs with presence of shorter incubation time, more rapid disease progression, and a higher rate of mortality have been lately described and may be due, in part, to enhanced induction of inflammation. TLRs are critical sensors in detecting infections and initially activate the innate immune system. S. suis is a pathogen that, in acute bacterial infections, will induce an exacerbated inflammatory reaction that contributes to the disease [23]. Within the family of TLRs, TLR2 has been implicated as the major pattern recognition receptor for ligands derived from Gram-positive bacteria [27]–[29]. In the case of S. suis, several in vitro studies with ST1 strains have previously shown that TLR2 plays an important role during bacterial interactions with mouse, swine and human cells [18]–[20], [30]. In addition, in vitro data suggest that activation pattern of TLR of typical ST1 European strains and that responsible for the Chinese human outbreak of toxic shock-like syndrome may slightly differ [20]. However, the in vivo contribution of TLR2 to the pathology of S. suis acute systemic infections has so far never been studied.
Our data indicate that in vivo TLR2-mediated recognition significantly contributes to the severe outcome following infection with a highly virulent S. suis ST1 strain. The absence of mortality could not be associated with a lower bacterial burden, suggesting that TLR2 would not be directly implicated in bacterial killing. In fact, recent results showed that dendritic cells from myeloid differentiation factor 88 deficient mice (MyD88−/−) presented similar rates of phagocytosis and killing of S. suis serotype 2 than cells isolated from WT mice [31], suggesting that TLRs would probably not be implicated in S. suis clearance. On the other hand, microarray, qRT-PCR, and/or protein assays confirmed a significantly lower induction of proinflammatory cytokines and chemokines in TLR2−/− mice that would correlate with survival, confirming previous in vitro results [18], [19]. Previous studies showed that the susceptibility of animals after experimental infection with S. suis serotype 2 clearly correlated with levels of inflammatory mediators in plasma rather than bacteremia [23]. Levels of proteins in plasma were similar to those obtained from homogenized spleen from infected mice (unpublished observations). In vivo results obtained with S. suis are similar to those reported by Mancuso et al. with Group B Streptococcus (GBS) who showed that, at high bacterial concentrations, TLR2−/− mice presented similar levels of bacteremia but considerably lower levels of inflammatory mediators and less mortality than WT mice [17]. However, and differently from S. suis, TLR2 plays an important role in controlling GBS infection when mice are infected with low doses of bacteria [17]. Infections with lower S. suis concentrations (≤5×106 CFU/mL) did not induce clinical disease in any of the mouse strains tested (results not shown). It is important to note that the pathogenesis of S. suis and GBS differ mainly in that the capsular polysaccharide of these pathogens present high or low anti-phagocytic properties, respectively [32].
Interestingly, inflammatory mediators were significantly reduced but not abolished in TLR2−/− infected mice, suggesting the contribution of other receptors. In vitro studies with S. suis ST1 strains recently showed that TLRs other than TLR2 as well as non-TLR receptors, such as nucleotide-binding oligomerization domain-like receptor (NLR) families, TLR3, TLR6 and TLR9 may also be involved in cell activation [31]. In fact, mice infected with very high doses of both S. suis ST1 and ST7 (≥ 1×108 CFU/mL) died within 72 h of infection indicating that although TLR2 seems to play an important role, in vivo activation of host cells by S. suis would require a multimodal recognition system (results not shown).
Serious outbreaks of S. suis STSLS in humans caused by an atypical strain have been reported during the last few years in China [33]. The ST7 strain was already shown to possess both higher inflammatory and virulence capacities than those of European and North American strains [22]. So far, the production of superantigens could not be proved for the epidemic strain [13]. However, a recent report showed some differences in receptor recognition in vitro between these two strain types [20]. Results observed in the present study indicate that TLR2 does not seem to be mainly implicated in the severe symptoms and lethality associated with the ST7 strain. Bacterial loads and induction of most proinflammatory cytokines and chemokines were independent of TLR2. We have recently reported that the higher mortality observed with the ST7 strain compared to ST1 strain was mainly due to a massive secretion of IFN-γ by Natural killer cells [24]. In the present study, levels of mRNA and protein of IFN-γ were significantly higher in ST7 compared to ST1-infected mice (P <0.05), confirming our previous observations. However, levels of this mediator were induced at similar levels by WT and TLR2−/− ST7-infected mice, which may explain, at least in part, similar levels of mortality in both mouse groups. It is quite possible that this particular strain of S. suis has a better capacity to stimulate other host receptors besides TLR2 during a systemic infection. As mentioned above, other TLR receptors (such as TLR3, TLR6 and TLR9) as well as other non-TLR receptors, such as NLR families, may also be involved in cell activation of this particular strain. So far, virulence factors that would be present in this strain (but absent in ST1 strains) that may be responsible for such differences have not been clearly identified [8]. The implication of lipoteichoic acid (LTA) in the activation of TLRs is still controversial [29], [34]. For GBS for example, it has been clearly demonstrated that secreted lipoproteins but not LTA are essential for TLR2 activation [35]. Cell-wall associated lipoproteins of S. suis have been suggested as being implicated on TLR2/6 but not TLR1/2 cell activation and this effect varies depending on the strain and serotype [30]. Further studies using isogenic mutants clearly demonstrated that lipoproteins are potent and dominant innate immunity activating molecules of S. suis [36]. These lipoproteins can be released after penicillin treatment or directly released in the supernatant [36]. However, receptors involved in the activation of these released bacterial components have not been elucidated. A recent study showed that differences on in vitro TLR activation between an European ST1 and the ST7 epidemic strain were observed also with washed heat killed suspensions, indicating a lower implication of secreted components [20]. Thus, we hypothesize that different bacterial components, especially differences in lipoproteins (secreted or not) present in typical S. suis strains and those from the epidemic S. suis ST7 strain may vary and play a distinct role on cell activation and in the pathogenesis of the systemic inflammatory disease caused by this pathogen. Results obtained in the present study with both ST1 and ST7 strains reinforce the concept of multiple Gram-positive cell receptors. Further investigations using different genetic mouse models defective in single TLRs, MyD88 or with double TLR deletions will help clarify the role of other receptors in the innate recognition of typical ST1 S. suis strains but mainly, the epidemic S. suis ST7 strain.
Results obtained in this study can be applied to the acute systemic infection caused by S. suis. However, S. suis is also able to induce meningitis in a mouse model of infection at later incubation times (between 5 and 14 days post-infection) [12]. Some cases of meningitis have also been induced in humans by the ST7 strain during the outbreak in China [22]. In fact, the actual in vivo role of TLR2 in meningitis caused by any strain of S. suis is unknown, and it would be difficult to predict. For example, it has been reported that TLR2 does not play a major role in Streptococcus pneumoniae killing and disease after either systemic disease or pneumonia [37], [38]. However, other studies showed that TLR2−/− mice are significantly more affected and have increased bacterial loads than WT mice in experimental meningitis [39], [40]. Although TLR2 has been suggested to be implicated in S. suis meningitis [41], further in vivo studies with TLR2−/− mice are warranted.
In summary, results obtained in this study reveal that infection of mice by highly pathogenic strains of S. suis may follow TLR2-dependent or independent pathways depending on the strain. The atypical epidemic ST7 strain, responsible for STSLS human cases, would not only induce a massive and distinctive IFN-γ response but also activate cells using currently unknown receptors which are different from those activated by highly virulent ST1 strains.
Supporting Information
Table S1.
Genes upregulated greater than three-fold in wild type C57BL/6 (B6) or TLR2−/− mice infected with either S. suis P1/7 (ST1) strain or epidemic SC84 (ST7) strain for 6 h.
https://doi.org/10.1371/journal.pone.0065031.s001
(DOCX)
Author Contributions
Conceived and designed the experiments: CL MS MG. Performed the experiments: CL PPG. Analyzed the data: CL PPG. Contributed reagents/materials/analysis tools: JX MG. Wrote the paper: CL MS MG.
References
- 1.
Gottschalk M (2012) Streptococcis. In: Zimmerman J, Karriker L, Ramirez A, Schwartz K, Stevenson G, editors. Diseases of Swine, Tenth Edition. Ames, IA: John Wiley & Sons, Inc.
- 2. Wisselink HJ, Smith HE, Stockhofe-Zurwieden N, Peperkamp K, Vecht U (2000) Distribution of capsular types and production of muramidase-released protein (MRP) and extracellular factor (EF) of Streptococcus suis strains isolated from diseased pigs in seven European countries. Vet Microbiol 74: 237–248.
- 3. Gottschalk M, Xu J, Calzas C, Segura M (2010) Streptococcus suis: a new emerging or an old neglected zoonotic pathogen? Future Microbiol 5: 371–391.
- 4. Hui AC, Ng KC, Tong PY, Mok V, Chow KM, et al. (2005) Bacterial meningitis in Hong Kong: 10-years' experience. Clin Neurol Neurosurg 107: 366–370.
- 5. Kerdsin A, Dejsirilert S, Puangpatra P, Sripakdee S, Chumla K, et al. (2011) Genotypic profile of Streptococcus suis serotype 2 and clinical features of infection in humans, Thailand. Emerg Infect Dis 17: 835–842.
- 6. Mai NT, Hoa NT, Nga TV, Linh le D, Chau TT, et al. (2008) Streptococcus suis meningitis in adults in Vietnam. Clin Infect Dis 46: 659–667.
- 7. Ye C, Zhu X, Jing H, Du H, Segura M, et al. (2006) Streptococcus suis sequence type 7 outbreak, Sichuan, China. Emerg Infect Dis 12: 1203–1208.
- 8. Fittipaldi N, Segura M, Grenier D, Gottschalk M (2012) Virulence factors involved in the pathogenesis of the infection caused by the swine pathogen and zoonotic agent Streptococcus suis. Future Microbiol 7: 259–279.
- 9. Lecours MP, Gottschalk M, Houde M, Lemire P, Fittipaldi N, et al. (2011) Critical role for Streptococcus suis cell wall modifications and suilysin in resistance to complement-dependent killing by dendritic cells. J Infect Dis 204: 919–929.
- 10. Vanier G, Segura M, Friedl P, Lacouture S, Gottschalk M (2004) Invasion of porcine brain microvascular endothelial cells by Streptococcus suis serotype 2. Infect Immun 72: 1441–1449.
- 11. Tenenbaum T, Papandreou T, Gellrich D, Friedrichs U, Seibt A, et al. (2009) Polar bacterial invasion and translocation of Streptococcus suis across the blood-cerebrospinal fluid barrier in vitro. Cell Microbiol 11: 323–336.
- 12. Dominguez-Punaro MC, Segura M, Plante MM, Lacouture S, Rivest S, et al. (2007) Streptococcus suis serotype 2, an important swine and human pathogen, induces strong systemic and cerebral inflammatory responses in a mouse model of infection. J Immunol 179: 1842–1854.
- 13. Zheng H, Ye C, Segura M, Gottschalk M, Xu J (2008) Mitogenic effect contributes to increased virulence of Streptococcus suis sequence type 7 to cause streptococcal toxic shock-like syndrome. Clin Exp Immunol 153: 385–391.
- 14. Gottschalk M, Segura M, Xu J (2007) Streptococcus suis infections in humans: the Chinese experience and the situation in North America. Anim Health Res Rev 8: 29–45.
- 15. Beutler B (2009) Microbe sensing, positive feedback loops, and the pathogenesis of inflammatory diseases. Immunol Rev 227: 248–263.
- 16. Kawai T, Akira S (2010) The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 11: 373–384.
- 17. Mancuso G, Midiri A, Beninati C, Biondo C, Galbo R, et al. (2004) Dual role of TLR2 and myeloid differentiation factor 88 in a mouse model of invasive group B streptococcal disease. J Immunol 172: 6324–6329.
- 18. Graveline R, Segura M, Radzioch D, Gottschalk M (2007) TLR2-dependent recognition of Streptococcus suis is modulated by the presence of capsular polysaccharide which modifies macrophage responsiveness. Int Immunol 19: 375–389.
- 19. Zheng H, Punaro MC, Segura M, Lachance C, Rivest S, et al. (2011) Toll-like receptor 2 is partially involved in the activation of murine astrocytes by Streptococcus suis, an important zoonotic agent of meningitis. J Neuroimmunol 234: 71–83.
- 20. Zheng H, Luo X, Segura M, Sun H, Ye C, et al. (2012) The role of toll-like receptors in the pathogenesis of Streptococcus suis. Vet Microbiol 156: 147–156.
- 21. Holden MT, Hauser H, Sanders M, Ngo TH, Cherevach I, et al. (2009) Rapid evolution of virulence and drug resistance in the emerging zoonotic pathogen Streptococcus suis. PLoS One 4: e6072.
- 22. Ye C, Zheng H, Zhang J, Jing H, Wang L, et al. (2009) Clinical, experimental, and genomic differences between intermediately pathogenic, highly pathogenic, and epidemic Streptococcus suis. J Infect Dis 199: 97–107.
- 23. Dominguez-Punaro MC, Segura M, Radzioch D, Rivest S, Gottschalk M (2008) Comparison of the susceptibilities of C57BL/6 and A/J mouse strains to Streptococcus suis serotype 2 infection. Infect Immun 76: 3901–3910.
- 24.
Lachance C, Gottschalk M, Gerber PP, Lemire P, Xu J, et al.. (2013) Exacerbated Type II Interferon Response Drives Hypervirulence and Toxic Shock by an Emergent Epidemic Strain of Streptococcus suis. Infect Immun.
- 25. Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, et al. (2009) The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 55: 611–622.
- 26. Taylor S, Wakem M, Dijkman G, Alsarraj M, Nguyen M (2010) A practical approach to RT-qPCR-Publishing data that conform to the MIQE guidelines. Methods 50: S1–5.
- 27. Han SH, Kim JH, Martin M, Michalek SM, Nahm MH (2003) Pneumococcal lipoteichoic acid (LTA) is not as potent as staphylococcal LTA in stimulating Toll-like receptor 2. Infect Immun 71: 5541–5548.
- 28. Kawai T, Akira S (2005) Pathogen recognition with Toll-like receptors. Curr Opin Immunol 17: 338–344.
- 29. Schroder NW, Morath S, Alexander C, Hamann L, Hartung T, et al. (2003) Lipoteichoic acid (LTA) of Streptococcus pneumoniae and Staphylococcus aureus activates immune cells via Toll-like receptor (TLR)-2, lipopolysaccharide-binding protein (LBP), and CD14, whereas TLR-4 and MD-2 are not involved. J Biol Chem 278: 15587–15594.
- 30. Wichgers Schreur PJ, Rebel JM, Smits MA, van Putten JP, Smith HE (2010) Differential activation of the Toll-like receptor 2/6 complex by lipoproteins of Streptococcus suis serotypes 2 and 9. Vet Microbiol 143: 363–370.
- 31. Lecours MP, Segura M, Fittipaldi N, Rivest S, Gottschalk M (2012) Immune receptors involved in Streptococcus suis recognition by dendritic cells. PLoS One 7: e44746.
- 32. Segura M (2012) Fisher scientific award lecture - the capsular polysaccharides of Group B Streptococcus and Streptococcus suis differently modulate bacterial interactions with dendritic cells. Can J Microbiol 58: 249–260.
- 33. Ye C, Bai X, Zhang J, Jing H, Zheng H, et al. (2008) Spread of Streptococcus suis sequence type 7, China. Emerg Infect Dis 14: 787–791.
- 34. Pietrocola G, Arciola CR, Rindi S, Di Poto A, Missineo A, et al. (2011) Toll-like receptors (TLRs) in innate immune defense against Staphylococcus aureus. Int J Artif Organs 34: 799–810.
- 35. Henneke P, Dramsi S, Mancuso G, Chraibi K, Pellegrini E, et al. (2008) Lipoproteins are critical TLR2 activating toxins in group B streptococcal sepsis. J Immunol 180: 6149–6158.
- 36. Wichgers Schreur PJ, Rebel JM, Smits MA, van Putten JP, Smith HE (2011) Lgt processing is an essential step in Streptococcus suis lipoprotein mediated innate immune activation. PLoS One 6: e22299.
- 37. Khan AQ, Chen Q, Wu ZQ, Paton JC, Snapper CM (2005) Both innate immunity and type 1 humoral immunity to Streptococcus pneumoniae are mediated by MyD88 but differ in their relative levels of dependence on toll-like receptor 2. Infect Immun 73: 298–307.
- 38. Knapp S, Wieland CW, van 't Veer C, Takeuchi O, Akira S, et al. (2004) Toll-like receptor 2 plays a role in the early inflammatory response to murine pneumococcal pneumonia but does not contribute to antibacterial defense. J Immunol 172: 3132–3138.
- 39. Echchannaoui H, Leib SL, Neumann U, Landmann RM (2007) Adjuvant TACE inhibitor treatment improves the outcome of TLR2−/− mice with experimental pneumococcal meningitis. BMC Infect Dis 7: 25.
- 40. Koedel U, Angele B, Rupprecht T, Wagner H, Roggenkamp A, et al. (2003) Toll-like receptor 2 participates in mediation of immune response in experimental pneumococcal meningitis. J Immunol 170: 438–444.
- 41. Dominguez-Punaro MC, Segura M, Contreras I, Lachance C, Houde M, et al. (2010) In vitro characterization of the microglial inflammatory response to Streptococcus suis, an important emerging zoonotic agent of meningitis. Infect Immun 78: 5074–5085.